GEN News Highlights: Feb 7, 2012

Brooks Life Science, Scripps Research to Work on Microplate Imaging System

(Page 1 of 1)

    Brooks Life Science Systems has initiated a technology development and commercialization partnership with The Scripps Research Institute. The deal includes an exclusive license to jointly complete the development of a microplate imaging system created by Scripps Research and to enable Brooks Life Science Systems to manufacture and commercialize this imaging system.

    The new Brooks Plate Auditor™ is being developed for compound management and high-throughput screening (HTS). “This technology was developed to address an unmet need in our compound management operation—the automated assessment of compound quality in plate-based HTS libraries,” explains Peter Hodder, Ph.D., senior director and head of lead identification at the Florida campus of Scripps Research. “Both HTS and compound management staff now consider it indispensable for routine quality control of cherry-picked samples as well as periodic monitoring of sample quality across all our screening libraries.”

    John Lillig, svp and managing director of Brooks Life Science Systems, notes, “With over 350 million samples stored in Brooks Sample Management Systems around the world, the new Plate Auditor will complement our Brooks Tube Auditor and be a valuable new quality enhancement tool for our compound management customers.”

    Scripps Research presented the technology in a talk entitled “A Novel Platform to Improve HTS Compound Management Operations” at the Society for Laboratory Automation and Screening conference in San Diego on Monday, February 6.


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA Performance

How much progress do you think FDA has made in reviewing drugs and bringing them to market faster?

Suggest a Poll